MLchartDataset catalogue

Rilutek

Term · Oncology and biomedicine · MLC-T-ONC-007454

A drug used to treat a nerve disease called amyotrophic lateral sclerosis (ALS). It is also being studied in the treatment of melanoma (a type of skin cancer). Rilutek blocks the release of a substance that melanoma cells need to grow. It is a type of glutamate release inhibitor. Also called riluzole.

Table 1. Record
IdentifierMLC-T-ONC-007454
FieldOncology and biomedicine
Synonymsriluzole
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-007454",
  "term": "Rilutek",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat a nerve disease called amyotrophic lateral sclerosis (ALS). It is also being studied in the treatment of melanoma (a type of skin cancer). Rilutek blocks the release of a substance that melanoma cells need to grow. It is a type of glutamate release inhibitor. Also called riluzole.",
  "synonyms": [
    "riluzole"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/rilutek/"
}

Record 14,491 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.